StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Apellis Pharmaceuticals, Inc.
NasdaqGS:APLS
Sector
Location
Market Cap
USD 2.50 B
Share Price
USD 19.90
Avg Daily Volume
2,459,340
Change (1 day)
0.05%
Change (1 year)
-46.04%
Change (YTD)
-37.64%
Apellis Pharmaceuticals, Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 23, 2025: -14.71
Apellis Pharmaceuticals, Inc. Enterprise Value to EBITDA (EV/EBITDA) is -14.71 on July 23, 2025, a -1.68% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Apellis Pharmaceuticals, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -11.99 on July 23, 2025, which is 18.51% above the current Enterprise Value to EBITDA (EV/EBITDA).
-
Apellis Pharmaceuticals, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -24.12 on July 23, 2025, which is -63.99% below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Apellis Pharmaceuticals, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -16.57.
Competitors
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Moderna, Inc.
USD 34.67
MRNA
+1.94
5.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.43
603392.SS
+0.06
0.69%
Swedish Orphan Biovitrum AB (publ)
USD 28.81
SOBI.ST
+0.48
1.70%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.03
300122.SZ
+0.15
5.21%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
+0.43
1.03%
Rhythm Pharmaceuticals, Inc.
USD 87.81
RYTM
-0.01
-0.01%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.12
3.93%
Vaxcyte, Inc.
USD 36.46
PCVX
+0.74
2.07%
Hualan Biological Engineering Inc.
USD 2.30
002007.SZ
+0.01
0.61%
NewAmsterdam Pharma Company N.V.
USD 23.98
NAMS
+1.05
4.58%
Ligand Pharmaceuticals Incorporated
USD 136.21
LGND
+3.75
2.83%
Apogee Therapeutics, Inc.
USD 40.58
APGE
+0.98
2.48%
Bavarian Nordic A/S
USD 30.28
BAVA.CO
+1.17
4.03%
Immunocore Holdings plc
USD 36.05
IMCR
-1.10
-2.96%
ARS Pharmaceuticals, Inc.
USD 18.00
SPRY
+0.41
2.33%
Adaptive Biotechnologies Corporation
USD 10.87
ADPT
+0.34
3.23%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Moderna, Inc.
USD 34.67
MRNA
+1.94
5.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.43
603392.SS
+0.06
0.69%
Swedish Orphan Biovitrum AB (publ)
USD 28.81
SOBI.ST
+0.48
1.70%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.03
300122.SZ
+0.15
5.21%
Ionis Pharmaceuticals, Inc.
USD 42.38
IONS
+0.43
1.03%
Rhythm Pharmaceuticals, Inc.
USD 87.81
RYTM
-0.01
-0.01%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.12
3.93%
Vaxcyte, Inc.
USD 36.46
PCVX
+0.74
2.07%
Hualan Biological Engineering Inc.
USD 2.30
002007.SZ
+0.01
0.61%
NewAmsterdam Pharma Company N.V.
USD 23.98
NAMS
+1.05
4.58%
Ligand Pharmaceuticals Incorporated
USD 136.21
LGND
+3.75
2.83%
Apogee Therapeutics, Inc.
USD 40.58
APGE
+0.98
2.48%
Bavarian Nordic A/S
USD 30.28
BAVA.CO
+1.17
4.03%
Immunocore Holdings plc
USD 36.05
IMCR
-1.10
-2.96%
ARS Pharmaceuticals, Inc.
USD 18.00
SPRY
+0.41
2.33%
Adaptive Biotechnologies Corporation
USD 10.87
ADPT
+0.34
3.23%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%